AMAG Pharmaceuticals, Inc. Submits New Drug Application To FDA For Ferumoxytol In Chronic Kidney Disease Patients (Medical News Today)
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for marketing approval of ferumoxytol as an intravenous treatment of iron deficiency anemia in patients with chronic kidney disease (CKD), including dialysis dependent and non-dialysis dependent patients. [click link for full article]

Abiomed Receives FDA Approval For The Combination IPulse Circulatory Support System (Medical News Today)
Abiomed, Inc. (NASDAQ: ABMD) announced that it has received approval from the U.S. Food and Drug Administration (FDA) for U.S. commercial distribution of the Company's combination iPulse Circulatory Support System. [click link for full article]